登录

"Menxlab Manshi" Completes ¥10M Angel Round of Financing

作者: Mailman 2020-02-10 17:37
Menxlab蔓狮
企业数据由 动脉橙 提供支持
男性健康产品研发、生产、销售商 | A轮 | 运营中
中国-广东
2020-10-12
融资金额:RMB¥1亿
华创资本
查看

According to lieyunwang.com, "Menxlab Manshi", a platform for men's health management, has completed its angel round financing of 10 million yuan, led by Gaorong Capital with participation from GF Xinde and other institutions. Proceeds of this financing will be used for product R&D, market promotion, and building a digital health management platform.


"Menxlab Manshi" is the first new brand of men's health management launched by Shenzhen Manshi Technology Co., Ltd. It mainly aims at the health problems of men aged 20-45 such as hair loss, health care and skin care, and provides them with medical consumer-grade products and comprehensive solutions.


Menxlab's original intention was to build a brand that focuses on men’s health and lifestyles, to allow more men to better understand and care for themselves, and to guide men through positive and healthy preventive self-care, focusing on their own and family health, and promoting men. Personal image and charm.


The Menxlab team believes that there are many brands on the market for women's care, but few are really targeted at men. Young men have been at the bottom of the consumption chain for a long time, and their needs are often ignored. However, with the trend of "treating the disease", more and more male consumers have begun to pay attention to their image and health management, and seek solutions. So Menxlab started to set up a laboratory last year to develop related products for men's health.


>>>>
About Gaorong Capital


Gaorong Capital is devoted to creating a better life through innovation. It is dedicated to identifying the leading founders and collaborating with them to achieve long-term value. Gaorong Capital focuses on the investment of innovations in technology and business models along with industrial integration.


>>>>

About GF Xinde Investment Management (GF Xinde)


Founded in 2008, GF Xinde is one of the leading direct investment brokerages in China. It provides distinct advantages in regards to investment resources, market research, professional expertise, mergers and acquisitions and IPO experience. The company has successfully created a number of diverse management funds: mezzanine funds, merger and acquisition funds, private equity funds, and other investment funds, covering a wide range of industries, such as medicine, consumer stocks, and the Internet.

注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

谷歌风投、OrbiMed等多家顶级投资机构,他们在海外投什么医疗企业

Menxlab Completes ¥10M Pre-A Round of Financing

Boohee Closes Series C Funding Round, Led by Fosun International

Yesalign Raises Millions of Yuan in Angel Funding Round

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

Universal Medical Snares ¥600M in Series B Financing

2020-02-10
下一篇

【生物医药日报】专家承认口误,新冠病毒不是SARS;核酸不再是唯一的诊断依据

2020-02-10